Intro

This chapter explores the evolution of Alzheimer’s disease diagnosis, moving from post-mortem autopsies to the use of advanced blood biomarkers. It highlights a collaborative study published in JAMA that reviews various FDA-approved diagnostic methods and their effectiveness in different healthcare settings.